News|Videos|November 6, 2024

Insulin Icodec Represents A Promising Option for Managing Diabetes, Improving Quality of Life

Author(s)Killian Meara

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, discusses how insulin icodec differs from existing daily basal insulins and key things pharmacists need to know about the medication.

In the United States, about 38 million people have diabetes and more than 1 in 3 Americans have prediabetes but are unaware of it.1 The prevalence of the disease in the country is also expected to continue increasing, with some research estimating that more than 54 million people will have diabetes by 2030.2 As diabetes represents a major health crisis in the US, increasing awareness and improving disease management are crucial.